BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19201411)

  • 1. Small dense LDL-cholesterol determined by a simple precipitation assay for screening familial combined hyperlipidemia.
    Hirano T; Nohtomi K; Sato Y; Kamata K; Ito Y
    Atherosclerosis; 2009 Aug; 205(2):603-7. PubMed ID: 19201411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia.
    Ayyobi AF; McGladdery SH; McNeely MJ; Austin MA; Motulsky AG; Brunzell JD
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1289-94. PubMed ID: 12750118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small dense low-density lipoprotein in familial combined hyperlipidemia: Independent of metabolic syndrome and related to history of cardiovascular events.
    Pauciullo P; Gentile M; Marotta G; Baiano A; Ubaldi S; Jossa F; Iannuzzo G; Faccenda F; Panico S; Rubba P
    Atherosclerosis; 2009 Mar; 203(1):320-4. PubMed ID: 18760784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype.
    Georgieva AM; van Greevenbroek MM; Krauss RM; Brouwers MC; Vermeulen VM; Robertus-Teunissen MG; van der Kallen CJ; de Bruin TW
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):744-9. PubMed ID: 14751815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parabolic relationship between plasma triacylglycerols and LDL-cholesterol in familial combined hyperlipidaemia: the multiple-type hyperlipidaemia explained?
    Brouwers MC; de Graaf J; van Greevenbroek MM; Georgieva AM; van der Kallen CJ; Ter Avest E; Stehouwer CD; Stalenhoef AF; de Bruin TW
    Clin Sci (Lond); 2008 Mar; 114(5):393-401. PubMed ID: 17953518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative assessment of LDL-C and VLDL-C estimation in familial combined hyperlipidemia using Sampson's, Martin's and Friedewald's equations.
    Vargas-Vázquez A; Bello-Chavolla OY; Antonio-Villa NE; Mehta R; Cruz-Bautista I; Aguilar-Salinas CA
    Lipids Health Dis; 2021 May; 20(1):46. PubMed ID: 33952259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of LDL-C calculated with Martin's formula compared to the Friedewald equation in familial combined hyperlipidemia.
    Mehta R; Reyes-Rodríguez E; Yaxmehen Bello-Chavolla O; Guerrero-Díaz AC; Vargas-Vázquez A; Cruz-Bautista I; A Aguilar-Salinas C
    Atherosclerosis; 2018 Oct; 277():204-210. PubMed ID: 29970255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial combined hyperlipidemia (FCHL) in children: the significance of early development of hyperapoB lipoproteinemia, obesity and aging.
    Kuromori Y; Okada T; Iwata F; Hara M; Noto N; Harada K
    J Atheroscler Thromb; 2002; 9(6):314-20. PubMed ID: 12560593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pravastatin effectively lowers LDL cholesterol in familial combined hyperlipidemia without changing LDL subclass pattern.
    Franceschini G; Cassinotti M; Vecchio G; Gianfranceschi G; Pazzucconi F; Murakami T; Sirtori M; D'Acquarica AL; Sirtori CR
    Arterioscler Thromb; 1994 Oct; 14(10):1569-75. PubMed ID: 7918306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma triglycerides and LDL cholesterol are related in a parabolic fashion in the general population and patients with Type 2 diabetes mellitus: long-term follow-up results from the Hoorn study.
    Brouwers MC; Dekker JM; van Greevenbroek MM; van der Kallen CJ; Heine RJ; de Bruin TW; Stehouwer CD
    Diabet Med; 2008 Sep; 25(9):1121-4. PubMed ID: 19183319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic evidence from 7 families that the apolipoprotein B gene is not involved in familial combined hyperlipidemia.
    Rauh G; Schuster H; Müller B; Schewe S; Keller C; Wolfram G; Zöllner N
    Atherosclerosis; 1990 Jul; 83(1):81-7. PubMed ID: 1975179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased intima-media thickness in familial combined hyperlipidemia associated with apolipoprotein B.
    Keulen ET; Kruijshoop M; Schaper NC; Hoeks AP; de Bruin TW
    Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):283-8. PubMed ID: 11834529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomogram to diagnose familial combined hyperlipidemia on the basis of results of a 5-year follow-up study.
    Veerkamp MJ; de Graaf J; Hendriks JC; Demacker PN; Stalenhoef AF
    Circulation; 2004 Jun; 109(24):2980-5. PubMed ID: 15184285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of cholestyramine in the treatment of children with familial combined hyperlipidemia.
    Liacouras CA; Coates PM; Gallagher PR; Cortner JA
    J Pediatr; 1993 Mar; 122(3):477-82. PubMed ID: 8441109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bimodality of plasma apolipoprotein B levels in familial combined hyperlipidemia.
    Austin MA; Horowitz H; Wijsman E; Krauss RM; Brunzell J
    Atherosclerosis; 1992 Jan; 92(1):67-77. PubMed ID: 1575822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of statins on LDL particle size in patients with familial combined hyperlipidemia: a comparison between atorvastatin and pravastatin.
    Sirtori CR; Calabresi L; Pisciotta L; Cattin L; Pauciullo P; Montagnani M; Manzato E; Bittolo Bon G; Fellin R
    Nutr Metab Cardiovasc Dis; 2005 Feb; 15(1):47-55. PubMed ID: 15871851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LDL particle size in familial combined hyperlipidemia: effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer proteins.
    Vakkilainen J; Jauhiainen M; Ylitalo K; Nuotio IO; Viikari JS; Ehnholm C; Taskinen MR
    J Lipid Res; 2002 Apr; 43(4):598-603. PubMed ID: 11907142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prothrombotic markers in familial combined hyperlipidemia: evidence of endothelial cell activation and relation to metabolic syndrome.
    Georgieva AM; Cate HT; Keulen ET; van Oerle R; Govers-Riemslag JW; Hamulyák K; van der Kallen CJ; Van Greevenbroek MM; De Bruin TW
    Atherosclerosis; 2004 Aug; 175(2):345-51. PubMed ID: 15262191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of evidence for linkage between low-density lipoprotein subclass phenotypes and the apolipoprotein B locus in familial combined hyperlipidemia.
    Austin MA; Wijsman E; Guo SW; Krauss RM; Brunzell JD; Deeb S
    Genet Epidemiol; 1991; 8(5):287-97. PubMed ID: 1761202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia.
    Austin MA; Brunzell JD; Fitch WL; Krauss RM
    Arteriosclerosis; 1990; 10(4):520-30. PubMed ID: 2369363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.